Assessment of Intersubject Variability in Small Airway Delivery with Oral Inhalation Drug Products (U01)
The summary for the Assessment of Intersubject Variability in Small Airway Delivery with Oral Inhalation Drug Products (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.
Assessment of Intersubject Variability in Small Airway Delivery with Oral Inhalation Drug Products (U01): FDA's CDER is seeking depositional data obtained with a computational modeling approach for small airway delivery to adults with orally inhaled drug products (OIDPs) that are indicated for management of asthma. Possible sources of intersubject variability include lengths and diameters of various airway segments, heterogeneous or homogeneous constriction, and inhalation patterns. An expected outcome is regional deposition data for reference listed drugs that can indicate whether or not the drug product targets small airways in asthmatic patients and the key product attributes that affects the deposition.
|Federal Grant Title:||Assessment of Intersubject Variability in Small Airway Delivery with Oral Inhalation Drug Products (U01)|
|Federal Agency Name:||Food and Drug Administration|
|Grant Categories:||Consumer Protection Food and Nutrition Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-FD-16-024|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||Food and Drug Administration_Research|
|Current Application Deadline:||May 16, 2016|
|Original Application Deadline:||May 16, 2016|
|Posted Date:||Mar 18, 2016|
|Creation Date:||Mar 18, 2016|
|Archive Date:||Jun 15, 2016|
|Total Program Funding:||$200,000|
|Maximum Federal Grant Award:||$200,000|
|Minimum Federal Grant Award:||none|
|Expected Number of Awards:||1|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Private institutions of higher education
Special district governments
City or township governments
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Public housing authorities/Indian housing authorities
- Additional Information on Eligibility
- Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- Full announcement of RFA-FD-16-024
- Grant Announcement Contact
- Eric Bozoian
Grants Management Specialist
Food and Drug Administration 240-402-7592
- More Grants from the Food and Drug Administration
- • FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
- • Drug Development Tools Research Grants (U01 Clinical Trial Not Allowed)
- • Rare Disease Clinical Outcome Assessment Consortium (U01 Clinical Trial Not Allowed)
- • Cigar Tobacco Reference Products Program (UC2) Clinical Trials Not Allowed
- • Implementation of U.S. Food Safety Modernization Act - Identifying, Researching, and Imple...